The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women
Background. Metabolic syndrome is a combination of cardiovascular risk factors (i.e., visceral obesity, dyslipidaemia, glucose intolerance, and hypertension), which entails critical issues in terms of medical management and public health. Methods. The aim of the present cross-sectional study was to...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2021/5576286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849306766557315072 |
|---|---|
| author | Antonello E. Rigamonti Sabrina Cicolini Sofia Tamini Diana Caroli Silvano G. Cella Alessandro Sartorio |
| author_facet | Antonello E. Rigamonti Sabrina Cicolini Sofia Tamini Diana Caroli Silvano G. Cella Alessandro Sartorio |
| author_sort | Antonello E. Rigamonti |
| collection | DOAJ |
| description | Background. Metabolic syndrome is a combination of cardiovascular risk factors (i.e., visceral obesity, dyslipidaemia, glucose intolerance, and hypertension), which entails critical issues in terms of medical management and public health. Methods. The aim of the present cross-sectional study was to investigate the age-related changes of the single IDF (International Diabetes Federation) diagnostic criteria for metabolic syndrome (waist circumference, WC; high-density lipoprotein cholesterol, HDL-C; triglycerides; glucose; systolic and diastolic blood pressure, SBP and DBP) in a large population of (Italian) obese women (n = 1.000; body mass index, BMI >30 kg/m2; age: 18–83 yrs), subdivided into two subgroups depending on the presence (n = 630) or absence (n = 370) of metabolic syndrome. Parallelly, the percentages of treatment with hypolipidaemic drugs, hypoglycaemics, and antihypertensives and, among the treated subjects, of control of the underlying condition in accordance with the cut-offs of IDF criteria for dyslipidaemia, hyperglycaemia, and hypertension were determined over six age ranges (i.e., 18–30, 31–40, 41–50, 51–60, 61–70, and > 70 yrs). Results. The prevalence of metabolic syndrome increased with advancing age. In the subgroup with metabolic syndrome, an age-dependent increase in HDL-C, glycaemia, and SBP occurred, while the visceral adiposity was stable. In the same subgroup, triglycerides and DBP decreased age-dependently. In the subgroup without metabolic syndrome, an age-dependent increase in WC, HDL-C, glycaemia, SBP, and DBP was observed. A progressive age-dependent increase in the percentage of patients pharmacologically treated for the cardiometabolic abnormalities was detected in patients with metabolic syndrome, a similar trend being also observed in patients without metabolic syndrome only for the antihypertensives. A clear-cut disproportion between treated versus adequately controlled women (with pharmacotherapy) was detected in the whole population. Conclusions. At least in an Italian context of obese females, the age-dependent worsening of glycaemia and BP exerts a fundamental pathophysiological role in the progressive increase of metabolic syndrome with advancing age, which appears to be not adequately treated in a large part of obese subjects. The results of the present study might be useful for public health decision-makers for programming future more extensive and aggressive non-pharmacological and pharmacological interventions in the obese population. |
| format | Article |
| id | doaj-art-23dd304f2dfd4ccb952715a75cc35304 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-23dd304f2dfd4ccb952715a75cc353042025-08-20T03:54:57ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/55762865576286The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese WomenAntonello E. Rigamonti0Sabrina Cicolini1Sofia Tamini2Diana Caroli3Silvano G. Cella4Alessandro Sartorio5University of Milan, Department of Clinical Sciences and Community Health, Milan 20129, ItalyInstituto Auxologico Italiano, IRCCS, Experimental Laboratory for Auxo-endocrinological Research, Piancavallo (VB) 28824, ItalyInstituto Auxologico Italiano, IRCCS, Experimental Laboratory for Auxo-endocrinological Research, Piancavallo (VB) 28824, ItalyInstituto Auxologico Italiano, IRCCS, Experimental Laboratory for Auxo-endocrinological Research, Piancavallo (VB) 28824, ItalyUniversity of Milan, Department of Clinical Sciences and Community Health, Milan 20129, ItalyInstituto Auxologico Italiano, IRCCS, Experimental Laboratory for Auxo-endocrinological Research, Piancavallo (VB) 28824, ItalyBackground. Metabolic syndrome is a combination of cardiovascular risk factors (i.e., visceral obesity, dyslipidaemia, glucose intolerance, and hypertension), which entails critical issues in terms of medical management and public health. Methods. The aim of the present cross-sectional study was to investigate the age-related changes of the single IDF (International Diabetes Federation) diagnostic criteria for metabolic syndrome (waist circumference, WC; high-density lipoprotein cholesterol, HDL-C; triglycerides; glucose; systolic and diastolic blood pressure, SBP and DBP) in a large population of (Italian) obese women (n = 1.000; body mass index, BMI >30 kg/m2; age: 18–83 yrs), subdivided into two subgroups depending on the presence (n = 630) or absence (n = 370) of metabolic syndrome. Parallelly, the percentages of treatment with hypolipidaemic drugs, hypoglycaemics, and antihypertensives and, among the treated subjects, of control of the underlying condition in accordance with the cut-offs of IDF criteria for dyslipidaemia, hyperglycaemia, and hypertension were determined over six age ranges (i.e., 18–30, 31–40, 41–50, 51–60, 61–70, and > 70 yrs). Results. The prevalence of metabolic syndrome increased with advancing age. In the subgroup with metabolic syndrome, an age-dependent increase in HDL-C, glycaemia, and SBP occurred, while the visceral adiposity was stable. In the same subgroup, triglycerides and DBP decreased age-dependently. In the subgroup without metabolic syndrome, an age-dependent increase in WC, HDL-C, glycaemia, SBP, and DBP was observed. A progressive age-dependent increase in the percentage of patients pharmacologically treated for the cardiometabolic abnormalities was detected in patients with metabolic syndrome, a similar trend being also observed in patients without metabolic syndrome only for the antihypertensives. A clear-cut disproportion between treated versus adequately controlled women (with pharmacotherapy) was detected in the whole population. Conclusions. At least in an Italian context of obese females, the age-dependent worsening of glycaemia and BP exerts a fundamental pathophysiological role in the progressive increase of metabolic syndrome with advancing age, which appears to be not adequately treated in a large part of obese subjects. The results of the present study might be useful for public health decision-makers for programming future more extensive and aggressive non-pharmacological and pharmacological interventions in the obese population.http://dx.doi.org/10.1155/2021/5576286 |
| spellingShingle | Antonello E. Rigamonti Sabrina Cicolini Sofia Tamini Diana Caroli Silvano G. Cella Alessandro Sartorio The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women International Journal of Endocrinology |
| title | The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women |
| title_full | The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women |
| title_fullStr | The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women |
| title_full_unstemmed | The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women |
| title_short | The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women |
| title_sort | age dependent increase of metabolic syndrome requires more extensive and aggressive non pharmacological and pharmacological interventions a cross sectional study in an italian cohort of obese women |
| url | http://dx.doi.org/10.1155/2021/5576286 |
| work_keys_str_mv | AT antonelloerigamonti theagedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT sabrinacicolini theagedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT sofiatamini theagedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT dianacaroli theagedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT silvanogcella theagedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT alessandrosartorio theagedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT antonelloerigamonti agedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT sabrinacicolini agedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT sofiatamini agedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT dianacaroli agedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT silvanogcella agedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen AT alessandrosartorio agedependentincreaseofmetabolicsyndromerequiresmoreextensiveandaggressivenonpharmacologicalandpharmacologicalinterventionsacrosssectionalstudyinanitaliancohortofobesewomen |